Back to results
US 2020/0048363 A1Published application
Anti-ox40 antibodies and their uses
AssigneeAbbVie Biotherapeutics Inc.
InventorFiona A. HARDING
Life of this patent
Estimating the term…
Abstract
The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
Claims5
An anti-OX40 antibody which is an IgG antibody consisting of heavy chains each consisting of the amino acid sequence of SEQ ID NO:41 and light chains each consisting of the amino acid sequence of SEQ ID NO:51.
-20. (canceled)
An anti-OX40 antibody which is an IgG antibody consisting of heavy chains each consisting of the amino acid sequence of SEQ ID NO:42 and light chains each consisting of the amino acid sequence of SEQ ID NO:51.
Dependencies are inferred from the claim text.